Atlas Trials

High-Frequency Transdermal Neuromodulation to Decrease Anxiety and Improve Sleep in ASD

Clinical trial NCT03859336 · COMPLETED

Trial details

NCT number
NCT03859336
Sponsor
Phoenix Children's Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Autism Spectrum Disorder
Start date
2019-05-21
Primary completion
2021-07-19
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.